Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole oral solution in children and adolescents with autism
CTR20180168Phase 3Completed
- Sponsor
- Sichuan Otsuka Pharmaceutical
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aripiprazole in Autism Spectrum Disorder (ASD), sponsored by Sichuan Otsuka Pharmaceutical. Started Feb 2018; status: completed.
02
Drugs
aripiprazole
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on CTR20180168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180168.